Vaccination, Symptomatic Infection and Negative Conversion of Viral RNA by Body Mass Index, Diabetes, and Age: an Observational Study

Victor W. Zhong,Xiaoguang Li,Jinjun Ran,Guanghui Hu,Shun Wei,Wei Zhai,Junhua Zheng,Hui Wang
DOI: https://doi.org/10.1016/j.vaccine.2022.10.014
IF: 4.169
2022-01-01
Vaccine
Abstract:Background: The associations of doses of vaccine received with symptomatic infection with SARS-CoV-2 and negative conversion rate of viral RNA by BMI, diabetes, and age are unclear.Methods: Included were adult cases of SARS-CoV-2 infection hospitalized at a makeshift hospital in Shanghai (N = 38,592). Each case received a real-time reverse transcriptase-polymerase chain reaction (RT-PCR) test every day until discharge. Symptomatic cases had >= 1 pre-specified symptoms. Negative conversion time (NCT) was the duration between the specimen collection date associated with the first positive RT-PCR test and the first test date of the two consecutive negative tests at least 24 h apart. BMI-, diabetes-and age-stratified multivariable logistic and Poisson regressions were applied.Findings: Coexistence of overweight/obesity and diabetes was associated with a higher risk of symp-tomatic infection and a longer NCT compared with coexistence of normal weight and without diabetes, but this association was primarily attributed to underlying comorbidities. Compared with absence of vac-cination, booster vaccination, but not full vaccination, was consistently associated with a 42 %-56 % lower odds of symptomatic infection and-1.6-1.8 days of shorter NCT across different strata separately for weight and diabetes. Age-stratified analyses found that the effectiveness of booster vaccination did not attenuate with age, except for preventing symptomatic infection among adults with diabetes. Interpretation: BMI and diabetes co-determined their associations with symptomatic infection and NCT. Booster vaccination but not full vaccination was associated a lower risk of symptomatic infection, a shorter NCT or both regardless of BMI, diabetes status and age.(c) 2022 Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?